Binding of the transmembrane PD-1 protein to its ligand, PD-L1, results in PD-1/T cell reoceptor inhibitory micro-clusters, which suppress the activation of T cells that could otherwise attack tumor cells [4]. The gene discussed is PDCD1; the disease is neoplasm.